SavedAdd your journal

Journals / Klinik Psikiyatri Dergisi / 2021 / Cilt: 24 - Sayı: 4

Methylphenidate treatment in an analgesic dependent adolescent with ADHD

Ayşegül Yolga TAHİROĞLU
Gonca ÇELİK
Ayse AVCI
Canan KUYGUN KARCI
Pages
564–566
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There are many explanations about this topic including complex interactions of genetic and environmental factors such as poor judgment or impulsive behavior in social settings, genetic susceptibility such as DRD2 genes, comorbid conduct disorder, and antisocial disorder (1,2).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Substance use disorder (SUD) is more common in the attention-deficit hyperactivity disorder (ADHD) group than in the non-ADHD group.
📊
Key Findings & Data:Substance use disorder (SUD) is more common in the attention-deficit hyperactivity disorder (ADHD) group than in the non-ADHD group.
💡
Conclusion & Impact:There are many explanations about this topic including complex interactions of genetic and environmental factors such as poor judgment or impulsive behavior in social settings, genetic susceptibility such as DRD2 genes, comorbid conduct disorder, and antisocial disorder (1,2).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Substance use disorder (SUD) is more common in the attention-deficit hyperactivity disorder (ADHD) group than in the non-ADHD group. There are many explanations about this topic including complex interactions of genetic and environmental factors such as poor judgment or impulsive behavior in social settings, genetic susceptibility such as DRD2 genes, comorbid conduct disorder, and antisocial disorder (1,2).

🔖

Cite This Article

TAHİROĞLU, A. Y., ÇELİK, G., AVCI, A., KARCI, C. K. (2021). Methylphenidate treatment in an analgesic dependent adolescent with ADHD. Klinik Psikiyatri Dergisi, Cilt: 24 - Sayı: 4, 564–566. https://ajindex.com/articles/413384

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Saad JF, Kohn MR, Clarke S, Lagopoulos J, Hermens DF. Is the Theta/Beta EEG Marker for ADHD Inherently Flawed? J Atten Disord. 2018 Jul;22(9):815-826
  2. Gloss D, Varma JK, Pringsheim T, Nuwer MR. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016 Nov 29;87(22):2375-2379
  3. Newson JJ, Thiagarajan TC. EEG Frequency Bands in Psychiatric Disorders: A Review of Resting State Studies. Front Hum Neurosci. 2019;12:521
  4. Widge AS, Bilge MT, Montana R, Chang W, Rodriguez CI, Deckersbach T, Carpenter LL, Kalin NH, Nemeroff CB. Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis. Am J Psychiatry. 2019 Jan 1;176(1):44-56
  5. Velasques B, Bittencourt J, Diniz C, Teixeira S, Basile LF, Inácio Salles J, Novis F, Angélica Silveira L, de Assis da Silva R, de Lima Teixeira A, Nardi AE, Akiskal HS, Cagy M, Piedade R, Cheniaux E, Kapczinki F, Ribeiro P. Changes in saccadic eye movement (SEM) and quantitative EEG parameter in bipolar patients. J Affect Disord. 2013 Mar 5;145(3):378-85
  6. McVoy M, Lytle S, Fulchiero E, Aebi ME, Adeleye O, Sajatovic M. A systematic review of quantitative EEG as a possible biomarker in child psychiatric disorders. Psychiatry Res. 2019 Sep;279:331-344
  7. Robar G. EEG in bipolar disorders - a literature review. Master thesis / Prosjektoppgave, 2006.
  8. Schiller MJ. Quantitative Electroencephalography in Guiding Treatment of Major Depression. Front Psychiatry. 2019 Jan 23;9:779.